Use of the post-insertion method for the formation of ligand-coupled liposomes.
Allen
Theresa M
TM
Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. terry.allen@ualberta.ca
Sapra
Puja
P
Moase
Elaine
E
D000818:Animals; D018941:Antigens, CD19 / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D007136:Immunoglobulins / Q000008:administration & dosage*; D008024:Ligands; D008055:Lipids; D008081:Liposomes; D008823:Micelles; D009842:Oligopeptides / Q000008:administration & dosage; D010714:Phosphatidylethanolamines; D011092:Polyethylene Glycols; D014750:Vincristine / Q000008:administration & dosage
D018941:Antigens, CD19; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D007136:Immunoglobulins; D008024:Ligands; D008055:Lipids; D008081:Liposomes; D008823:Micelles; D009842:Oligopeptides; D010714:Phosphatidylethanolamines; C095573:arginyl-tryptophyl-N-methylphenylalanyl-tryptophyl-leucyl-methioninamide; C038089:1,2-distearoylphosphatidylethanolamine; D011092:Polyethylene Glycols; D014750:Vincristine